Jefferies Group Reiterates $72.00 Price Target for Cardinal Health
The firm presently has a "hold" rating on the stock. Jefferies Group's price target points to a potential upside of 7.91% from the stock's current price.
from Biotech News
The firm presently has a "hold" rating on the stock. Jefferies Group's price target points to a potential upside of 7.91% from the stock's current price.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments